dc.creator | Raushel, Frank M. | |
dc.creator | Bigley, Andrew N. | |
dc.date.accessioned | 2019-06-17T17:16:07Z | |
dc.date.available | 2019-06-17T17:16:07Z | |
dc.date.issued | 2019-05-28 | |
dc.identifier.uri | https://hdl.handle.net/1969.1/177296 | |
dc.description.abstract | Variants of phosphotriesterase have been created that exhibit enhanced hydrolysis of V-type and G-type nerve agents over wild-type phosphotriesterase. V- and G-type nerve agents have an SP and RP enantiomer. The SP enantiomers are more toxic. V-type nerve agents are among the most toxic substances known. Variants of phosphotriesterase can prefer to hydrolyze one enantiomer of VX over the other enantiomer. | en |
dc.language | eng | |
dc.publisher | United States. Patent and Trademark Office | |
dc.rights | Public Domain (No copyright - United States) | en |
dc.rights.uri | http://rightsstatements.org/vocab/NoC-US/1.0/ | |
dc.title | Variants of phosphotriesterase for the hydrolysis and detoxification of nerve agents | en |
dc.type | Utility patent | en |
dc.format.digitalOrigin | reformatted digital | en |
dc.description.country | US | |
dc.contributor.assignee | The Texas A&M University System | |
dc.identifier.patentapplicationnumber | 15/320490 | |
dc.date.filed | 2015-06-19 | |
dc.publisher.digital | Texas A&M University. Libraries | |
dc.subject.cpcprimary | C12N 9/16 | |
dc.subject.cpcprimary | A62D 3/02 | |
dc.subject.cpcprimary | C12Y 301/03008 | |
dc.subject.cpcprimary | C12Y 301/08001 | |
dc.subject.cpcprimary | A62D 2101/02 | |
dc.subject.cpcprimary | A62D 2101/26 | |